12:00 AM
 | 
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fycompa perampanel regulatory update

FDA approved epilepsy drug Fycompa perampanel from Eisai as adjunct treatment for partial onset seizures in patients with epilepsy ages...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >